Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.15, 2004-01, pp. : 967-992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration

By Comer Grant M Ciulla Thomas A Heier Jeffery S Criswell Mark H

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 119-135

Informa Healthcare

Access to resources Recommend Favorite

Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration

By Stewart Michael W

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 103-113

Informa Healthcare

Access to resources Recommend Favorite

Current and future therapies for age-related macular degeneration

By Beutel Julia Rudolf Martin Grisanti Salvatore

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 341-362

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite